whitepaper

Whitepaper: Automated cell culture and screening

Posted: 8 February 2021 | | No comments yet

This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic screening, using validated phenotypic assays.

Effective drug discovery and development relies heavily on the availability of predictive preclinical models. Successful drug efficacy screening requires not only a physiologically relevant cell model, but also validated high throughput screening protocols to test compound effects. This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic compound screening, using validated phenotypic assays.











    To read this whitepaper in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Ncardia

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

     

    Send this to a friend